Department of Dermatology, Wuxi 9th Affiliated Hospital of Soochow University, Wuxi, China.
Department of Dermatology, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Second Chinese Medicine Hospital, Nanjing, China.
Ann Palliat Med. 2021 Nov;10(11):11643-11652. doi: 10.21037/apm-21-2685.
Chronic eczema has the characteristics of a long treatment cycle and repeated attacks, which seriously affects the daily life and work of patients. Topical glucocorticoids are the first-line treatment for chronic eczema. This study aimed to retrospectively analyze the effects of halometasone cream combined with Simiao pill on the efficacy and expression of serum leukotriene B4 (LTB4) and thymic stromal lymphopoietin (TSLP) in patients with eczema, and identify the factors influencing its clinical efficacy.
We retrospectively collected the medical records of 195 patients with chronic eczema treated in the dermatology department from January 2020 to May 2021, and divided them into two groups according to medication: 98 cases were treated with halometasone cream (control group) and 97 cases were treated with halometasone ointment combined with Simiao pill (observation group). The severity of eczema, quality of life, clinical efficacy, LTB4 and TSLP levels, and safety were compared between the two groups. Multivariate logistic regression analysis was used to determine the independent factors affecting clinical efficacy.
After treatment, the Eczema area and severity index (EASI) and Dermatology Life Quality Index (DLQI) scores in the observation group were markedly lower than those of the control group (P<0.05). The total clinical effective rate of the observation group was 88.8%, which was notably higher than that of the control group 70.1% (P=0.001). The concentrations of serum LTB4 and TSLP in the observation group were markedly lower than those in the control group (P<0.05). Logistic regression analysis showed that the treatment regimen, digestive system symptoms, heavy aching limbs, and damp-heat tongue and pulse were independent factors affecting the curative effect of the patients (P<0.05).
Simiao pill combined with halometasone cream can effectively improve chronic eczema and enhance the clinical efficacy of treatment, which may be related to the reduction of serum LTB4 and TSLP levels. The treatment plan, digestive system symptoms, heavy aching limbs, and damp-heat tongue and pulse are the main factors that affecting the clinical curative effect. Thus, clinical intervention programs should be made according to the above factors to improve the quality of life of patients.
慢性湿疹具有治疗周期长、反复发作的特点,严重影响患者的日常生活和工作。局部糖皮质激素是治疗慢性湿疹的一线药物。本研究旨在回顾性分析卤米松乳膏联合四妙丸治疗湿疹的疗效及对血清白三烯 B4(LTB4)和胸腺基质淋巴细胞生成素(TSLP)表达的影响,并探讨其临床疗效的影响因素。
收集 2020 年 1 月至 2021 年 5 月在皮肤科就诊的 195 例慢性湿疹患者的病历资料,按用药情况分为卤米松乳膏组(对照组,98 例)和卤米松乳膏联合四妙丸组(观察组,97 例)。比较两组患者湿疹严重程度、生活质量、临床疗效、LTB4 和 TSLP 水平及安全性。采用多因素 logistic 回归分析确定影响临床疗效的独立因素。
治疗后观察组患者的湿疹面积及严重度指数(EASI)评分和皮肤病生活质量指数(DLQI)评分均显著低于对照组(P<0.05)。观察组患者的总临床有效率为 88.8%,显著高于对照组的 70.1%(P=0.001)。观察组患者血清 LTB4 和 TSLP 浓度均显著低于对照组(P<0.05)。Logistic 回归分析显示,治疗方案、消化系统症状、四肢沉重疼痛、湿热舌脉是影响患者疗效的独立因素(P<0.05)。
四妙丸联合卤米松乳膏能有效改善慢性湿疹,提高临床疗效,可能与降低血清 LTB4 和 TSLP 水平有关。治疗方案、消化系统症状、四肢沉重疼痛、湿热舌脉是影响临床疗效的主要因素。因此,应根据上述因素制定临床干预方案,提高患者的生活质量。